The Royal Australian College of GPs (RACGP) has challenged the Pharmacy Guild to publicly release the research behind its latest push to expand pharmacy prescribing in Victoria, warning that patients and politicians deserve more than unverified industry claims.
The Guild has cited Deloitte modelling suggesting expanded pharmacy services could deliver up to $867 million in annual economic benefits, as it lobbies for pharmacists to treat chronic conditions including asthma, high blood pressure, and type 2 diabetes.
However, the full report has not been made publicly available, while reported modelling excludes implementation costs and projected benefits fall significantly under different assumptions.
RACGP Victoria Chair Dr Anita Muñoz said Victorians should question claims made by a powerful industry lobby group unwilling to publicly disclose the evidence behind them.
"When you commission research to support a policy that could benefit your members financially, the very least you can do is make that research available for independent scrutiny," she said.
"It is also unclear whether the modelling accounts for costs transferred to the Victorian health system, including the downstream costs of duplicated care, missed or delayed diagnoses, inappropriate treatment and avoidable hospital presentations. The Victorian public deserves to know the full costs.
"At a time of severe fiscal pressure, the Victorian government cannot afford to invest in a program that may ultimately costs more than it saves.
"The Guild donated more than $600,000 to political parties last financial year. It's entitled to lobby governments, but it can't expect politicians to accept its research at face value while keeping the full findings from public scrutiny.
"If the evidence is as compelling as the Guild suggests, why won't it put the full report on the table? What does it have to hide?
"Healthcare policy must be driven by independent evidence, not selective figures from industry-funded research."
The Sax Institute and Grattan Institute have already highlighted significant gaps in the evidence supporting expanded pharmacy prescribing and called for more rigorous evaluation.
In September, the RACGP joined other leading medical organisations in calling for independent evaluation of Victoria's Chemist Care Now program, including patient outcomes, adverse events and broader health system impacts.
"Conditions like diabetes and high blood pressure are complex chronic conditions that require comprehensive assessment, accurate diagnosis, ongoing monitoring, and coordinated care," Dr Muñoz said.
"These are serious conditions and the wrong treatment can lead to potentially life-threatening complications. They should not be reduced to simple, transactional conditions that can be managed in isolation at a pharmacy counter.
"The Guild's ambitions are also at odds with the warnings coming from pharmacists themselves."
Last weekend, industrial action by pharmacists closed stores across Victoria and South Australia amid concerns about staffing, workloads, and working conditions.
Professional Pharmacists Australia – the body representing non-owner community pharmacists – has separately warned that expanding prescribing without substantial improvements in training, staffing, and employment conditions could put patients and pharmacists at risk.
"The Guild represents pharmacy business owners, not the pharmacists who are warning that their workloads are already unsafe," Dr Muñoz said.
"Before politicians hand pharmacies more clinical responsibilities, they should listen to the health professionals actually doing the work.
"Victorians deserve safe, connected healthcare backed by transparent evidence. We urge all political parties to demand the full research, commit to robust independent evaluation and put patient safety ahead of commercial interests."